During the past decade, NorCal Endocrinology and Internal Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NorCal Endocrinology and Internal Medicine" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Insulet Corporation" with 1 trials as a collaborator and "Mylan GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "NorCal Endocrinology and Internal Medicine" are "Diabetes Mellitus, Type 1" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "NorCal Endocrinology and Internal Medicine" in a lesser frequency.

Most popular intervention types in "NorCal Endocrinology and Internal Medicine" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (1 trials), "Empagliflozin" (1 trials), "FlexPen NovoLog®" (1 trials), "Human regular U-500 insulin (CSII)" (1 trials) and "Human regular U-500 insulin (MDI)" (1 trials). Other intervention names were less common.

The vast majority of trials in "NorCal Endocrinology and Internal Medicine" are 4 trials for "All" genders.

Currently, there are NaN active trials in "NorCal Endocrinology and Internal Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in NorCal Endocrinology and Internal Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NorCal Endocrinology and Internal Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".